Completed OBSERVATIONAL NCT00420173

Interdisciplinary Study Group of Lupus Erythematosus (ISGLE)

Interdisciplinary Study Group of Lupus Erythematosus

Sponsor: European Society of Cutaneous Lupus Erythematosus e.V.

Conditions Cutaneous Lupus Erythematosus

Updated 7 times since 2017 Last updated: Dec 11, 2013 Started: Sep 30, 2004 Primary completion: Jul 31, 2005 Completion: Jun 30, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00420173, this observational or N/A phase trial focuses on Cutaneous Lupus Erythematosus and remains completed. Sponsored by European Society of Cutaneous Lupus Erythematosus e.V., it has been updated 7 times since 2004, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed

▶ Show 2 earlier versions

Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Sep 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

European Society of Cutaneous Lupus Erythematosus e.V.

Data source: European Society of Cutaneous Lupus Erythematosus e.V.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Münster, Germany